Is a complete HOWL research report available?

No complete published report is available for Werewolf Therapeutics, Inc. (HOWL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Werewolf Therapeutics, Inc. (HOWL)

NASDAQ: HOWL · USD

$1.07

+0.02 (+2.4%)· Recorded snapshot

Market cap	51.8M
Revenue (ttm)	21M
Net income (ttm)	-34.6M
EPS (ttm)	-$0.75
Shares out	48.6M
Volume	377,991
Beta	0.51

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21M
Net income (ttm): -34.6M
EPS (ttm): -$0.75
Market cap: 51.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001785530
Company name	Werewolf Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	95075A107
Earnings date	2026-11-10
Earnings time	bmo
Employees	14
Employees change	-25
Employees growth	-64.1%
Enterprise value	$29.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Biotechnology
IPO date	2021-04-30
Is primary listing	Yes
Is SPAC	No
ISIN number	US95075A1079
Last 10-K release date	2026-03-27
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$51.8M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$1.07
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	HOWL
U.S. state	Massachusetts
Website	https://werewolftx.com

Metric

Value

Amount currency

USD

CIK code

0001785530

Company name

Werewolf Therapeutics, Inc.

Country

United States

Country code

CUSIP number

95075A107

Earnings date

2026-11-10

Earnings time

bmo

Employees

Employees change

-25

Employees growth

-64.1%

Enterprise value

$29.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

Industry

Biotechnology

IPO date

2021-04-30

Is primary listing

Yes

Is SPAC

ISIN number

US95075A1079

Last 10-K release date

2026-03-27

Last earnings date

2026-07-31

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$51.8M

Market cap category

Micro-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$1.07

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

HOWL

U.S. state

Massachusetts

Website

https://werewolftx.com

Metric	Value
Earnings yield	-70.44%
EV/Sales	1.36x
FCF / EV yield	-105.57%
FCF yield	-59.65%
P/B ratio	3.1x
P/S ratio	2.41x
Price / tangible book value	3.1x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-70.44%

EV/Sales

1.36x

FCF / EV yield

-105.57%

FCF yield

-59.65%

P/B ratio

3.1x

P/S ratio

2.41x

Price / tangible book value

3.1x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
EBIT margin	-121.78%
EBITDA margin	-104.39%
Gross margin	-24.69%
Operating margin	-121.78%
Pretax margin	-164.82%
Profit margin	-164.82%
Profit per employee	$-2.5M
Profitable quarters	1
Revenue per employee	$1.5M
ROA	-27.39%
ROA (5Y)	-25.52%
ROCE	-156.97%
ROE	-119.86%
ROE (5Y)	-62.52%
ROIC	-33.68%
SBC / revenue	18.07%

Metric

Value

EBIT margin

-121.78%

EBITDA margin

-104.39%

Gross margin

-24.69%

Operating margin

-121.78%

Pretax margin

-164.82%

Profit margin

-164.82%

Profit per employee

$-2.5M

Profitable quarters

Revenue per employee

$1.5M

ROA

-27.39%

ROA (5Y)

-25.52%

ROCE

-156.97%

ROE

-119.86%

ROE (5Y)

-62.52%

ROIC

-33.68%

SBC / revenue

18.07%

Metric	Value
EPS growth quarters	5
EPS growth years	1
Net income growth quarters	4
Net income growth years	1
Revenue growth 3Y	-5.39%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth 3Y

-5.39%

Revenue growth years

Metric	Value
Depreciation and amortization	$3.7M
EBIT	$-25.6M
EBITDA	$-21.9M
EPS	$-0.75
FCF per share	$-0.62
Financing cash flow	$-26.8M
Free cash flow	$-30.1M
Free cash flow minus SBC	$-33.9M
Gross profit	$-5.2M
Investing cash flow	$416,000
Net borrowing	$-32.4M
Net cash flow	$-56.5M
Net income	$-34.6M
Operating cash flow minus SBC	$-33.9M
Operating income	$-25.6M
Revenue	$21M
Stock-based compensation	$3.8M

Metric

Value

Depreciation and amortization

$3.7M

EBIT

$-25.6M

EBITDA

$-21.9M

EPS

$-0.75

FCF per share

$-0.62

Financing cash flow

$-26.8M

Free cash flow

$-30.1M

Free cash flow minus SBC

$-33.9M

Gross profit

$-5.2M

Investing cash flow

$416,000

Net borrowing

$-32.4M

Net cash flow

$-56.5M

Net income

$-34.6M

Operating cash flow minus SBC

$-33.9M

Operating income

$-25.6M

Revenue

$21M

Stock-based compensation

$3.8M

Metric	Value
Altman Z-Score	-26.51
Book value per share	$0.34
Debt / equity	0
Interest coverage	-5.62
Long-term assets	$1.3M
Long-term liabilities	$0
Net cash (debt)	$22M
Net cash / market cap	43.5%
Net cash growth	-45.64%
Net debt / equity	-1.35
Piotroski F-Score	1
Property, plant and equipment	$1.3M
Shareholders' equity	$16.3M
Tangible book value	$16.3M
Tangible book value per share	$0.34
Total assets	$24.2M
Total cash	$22M
Total debt	$0
Total liabilities	$7.9M
WACC	7.06%

Metric

Value

Altman Z-Score

-26.51

Book value per share

$0.34

Debt / equity

Interest coverage

-5.62

Long-term assets

$1.3M

Long-term liabilities

Net cash (debt)

$22M

Net cash / market cap

43.5%

Net cash growth

-45.64%

Net debt / equity

-1.35

Piotroski F-Score

Property, plant and equipment

$1.3M

Shareholders' equity

$16.3M

Tangible book value

$16.3M

Tangible book value per share

$0.34

Total assets

$24.2M

Total cash

$22M

Total debt

Total liabilities

$7.9M

WACC

7.06%

Metric	Value
Asset turnover	0.36
Current assets	$22.9M
Current liabilities	$7.9M
Current ratio	2.91
Net working capital	$-7M
Quick ratio	2.8
Working capital	$15M
Working capital turnover	0.52

Metric

Value

Asset turnover

0.36

Current assets

$22.9M

Current liabilities

$7.9M

Current ratio

2.91

Net working capital

$-7M

Quick ratio

2.8

Working capital

$15M

Working capital turnover

0.52

Metric	Value
Buyback yield / dilution	-7.56%
Dividend yield	0%
Shareholder yield	-7.56%

Metric

Value

Buyback yield / dilution

-7.56%

Dividend yield

Shareholder yield

-7.56%

Metric	Value
150-day SMA	$0.68
1D price change	2.4%
1M price change	10.95%
1M total return	10.95%
1W price change	1.43%
1W total return	1.43%
1Y price change	-36.98%
1Y return CAGR	-37%
1Y total return	-36.98%
20-day SMA	$0.98
200-day SMA	$0.68
3M price change	134.94%
3M total return	134.94%
3Y price change	-56.71%
3Y return CAGR	-24.35%
3Y total return	-56.71%
50-day SMA	$0.94
50-day SMA vs 200-day SMA	50over200
52-week high	$1.72
52-week high date	2025-10-28
52-week low	$0.27
52-week low date	2026-06-29
5Y price change	-93.11%
5Y return CAGR	-41.44%
5Y total return	-93.11%
6M price change	28.31%
6M total return	28.31%
All-time high	$23.99
All-time high date	2021-04-30
All-time low	$0.27
All-time low date	2026-06-29
Average true range (ATR)	$0.05
Average volume	407.9K
Beta (1Y)	-0.23
Beta (2Y)	1.52
Beta (5Y)	0.51
Change from 52-week high	-38.08%
Change from 52-week low	294.44%
Change from all-time high	-95.56%
Change from all-time low	294.44%
Change from open	3.4%
Day's gap	-0.96%
Dollar volume	$402,560
High price	$1.08
Low price	$1.03
Monthly RSI	43.93
Open price	$1.03
Position in 52-week range	72.73%
Premarket change	-0.05%
Premarket close	$1.04
Premarket price	$1.04
Previous close	$1.04
Price vs 150-day SMA	57.73%
Price vs 20-day SMA	8.7%
Price vs 200-day SMA	57.29%
Price vs 50-day SMA	12.95%
Relative volume	0.93
Return from IPO open	-94.29%
Return from IPO price	-93.5%
RSI	64.99
Sharpe ratio	0.24
Sharpe ratio (3Y)	0.35
Sharpe ratio (5Y)	0
Sortino ratio	0.51
Sortino ratio (3Y)	0.7
Sortino ratio (5Y)	0.06
Volume	378K
Weekly RSI	66.44
YTD price change	68.11%
YTD total return	68.11%

Metric

Value

150-day SMA

$0.68

1D price change

2.4%

1M price change

10.95%

1M total return

10.95%

1W price change

1.43%

1W total return

1.43%

1Y price change

-36.98%

1Y return CAGR

-37%

1Y total return

-36.98%

20-day SMA

$0.98

200-day SMA

$0.68

3M price change

134.94%

3M total return

134.94%

3Y price change

-56.71%

3Y return CAGR

-24.35%

3Y total return

-56.71%

50-day SMA

$0.94

50-day SMA vs 200-day SMA

50over200

52-week high

$1.72

52-week high date

2025-10-28

52-week low

$0.27

52-week low date

2026-06-29

5Y price change

-93.11%

5Y return CAGR

-41.44%

5Y total return

-93.11%

6M price change

28.31%

6M total return

28.31%

All-time high

$23.99

All-time high date

2021-04-30

All-time low

$0.27

All-time low date

2026-06-29

Average true range (ATR)

$0.05

Average volume

407.9K

Beta (1Y)

-0.23

Beta (2Y)

1.52

Beta (5Y)

0.51

Change from 52-week high

-38.08%

Change from 52-week low

294.44%

Change from all-time high

-95.56%

Change from all-time low

294.44%

Change from open

3.4%

Day's gap

-0.96%

Dollar volume

$402,560

High price

$1.08

Low price

$1.03

Monthly RSI

43.93

Open price

$1.03

Position in 52-week range

72.73%

Premarket change

-0.05%

Premarket close

$1.04

Premarket price

$1.04

Previous close

$1.04

Price vs 150-day SMA

57.73%

Price vs 20-day SMA

8.7%

Price vs 200-day SMA

57.29%

Price vs 50-day SMA

12.95%

Relative volume

0.93

Return from IPO open

-94.29%

Return from IPO price

-93.5%

RSI

64.99

Sharpe ratio

0.24

Sharpe ratio (3Y)

0.35

Sharpe ratio (5Y)

Sortino ratio

0.51

Sortino ratio (3Y)

0.7

Sortino ratio (5Y)

0.06

Volume

378K

Weekly RSI

66.44

YTD price change

68.11%

YTD total return

68.11%

Metric	Value
Float	45.4M
Float percentage	93.38%
Shares change (QoQ)	0%
Shares change (YoY)	7.56%
Shares held by insiders	6.62%
Shares held by institutions	42.28%
Shares outstanding	48.6M
Short % of float	5.19%
Short % of shares	4.85%
Short ratio	3 days

Metric

Value

Float

45.4M

Float percentage

93.38%

Shares change (QoQ)

Shares change (YoY)

7.56%

Shares held by insiders

6.62%

Shares held by institutions

42.28%

Shares outstanding

48.6M

Short % of float

5.19%

Short % of shares

4.85%

Short ratio

3 days

Werewolf Therapeutics, Inc. (HOWL)

Price

Financial snapshot

Fair-value bridge

Latest news · HOWL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HOWL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HOWL

Frequently asked questions